New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic Anne C. Teirlinck, Caroline K. Johannesen, Eeva K. Broberg, Pasi Penttinen, Harry Campbell, Harish Nair, Rachel M. Reeves, Håkon Bøås, Mia Brytting, Wei Cai, AnnaSara Carnahan, Jean-Sebastien Casalegno, Kostas Danis, Cillian De Gascun, Joanna Ellis, Hanne-Dorthe Emborg, Manuel Gijon, Raquel Guiomar, Siddhivinayak S. Hirve, Helena Jirincová, Hanna Nohynek, Jesus Angel Oliva, Richard Osei-Yeboah, John Paget, Gatis Pakarna, Richard Pebody, Lance Presser, Marie Rapp, Janine Reiche, Ana Paula Rodrigues, Elina Seppälä, Maja Socan, Karol Szymanski, Ramona Trebbien, Jaromíra Vecerová, Sylvie van der Werf, Maria Zambon, Adam Meijer, Thea K. Fischer Eur Respir J, 61 (4) 2201569; 10.1183/13993003.01569-2022 | |
Pushing (for) GOLD Mark Dransfield, Ravi Kalhan, Daiana Stolz Eur Respir J, 61 (4) 2300366; 10.1183/13993003.00366-2023 | |
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet Mattia Nigro, James D. Chalmers, Stefano Aliberti Eur Respir J, 61 (4) 2300270; 10.1183/13993003.00270-2023 | |
Panta rhei (???ta ?e?), or everything flows with long COVID Joan B. Soriano, Jessica González, Antoni Torres Eur Respir J, 61 (4) 2202490; 10.1183/13993003.02490-2022 | |
Transmission of Mycobacterium avium complex in healthcare settings: from environment, person to person, or both? Charles L. Daley, Nabeeh Hasan Eur Respir J, 61 (4) 2300308; 10.1183/13993003.00308-2023 | |
Obstructive sleep apnoea, nocturnal hypoxaemia, and cognitive decline in elderly patients AbdelKebir Sabil, Frédéric Gagnadoux Eur Respir J, 61 (4) 2300300; 10.1183/13993003.00300-2023 | |
Another piece in the pirfenidone puzzle Mareike Lehmann, Martin Kolb Eur Respir J, 61 (4) 2300240; 10.1183/13993003.00240-2023 | |
The alternative approach: genomic classifiers for prognostication in interstitial lung disease Gillian C. Goobie, Sabina A. Guler Eur Respir J, 61 (4) 2300033; 10.1183/13993003.00033-2023 | |
The effects of elexafactor/tezafactor/ivacaftor beyond the epithelium: spurring macrophages to fight infections Emanuela M. Bruscia Eur Respir J, 61 (4) 2300216; 10.1183/13993003.00216-2023 | |
Lung volume reduction in COPD: scope or surgery Francesca Polverino, Frank Sciurba Eur Respir J, 61 (4) 2300353; 10.1183/13993003.00353-2023 | |
COPD pathophysiology: climbing the waterfall of cell death to find a target Didier Cataldo Eur Respir J, 61 (4) 2300093; 10.1183/13993003.00093-2023 | |
Defining the questions to be asked in severe asthma trials: data from the COMSA working group Thomas Eiwegger, Sarah A. Bendien Eur Respir J, 61 (4) 2202058; 10.1183/13993003.02058-2022 | |
Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials Alexander G. Mathioudakis, Ekaterina Khaleva, Markus Fally, Paula R. Williamson, Jens-Ulrik Jensen, Tim W. Felton, Chris Brightling, Andrew Bush, Tonya Winders, John Linnell, Valeria Ramiconi, Courtney Coleman, Tobias Welte, Graham Roberts, Jørgen Vestbo Eur Respir J, 61 (4) 2202107; 10.1183/13993003.02107-2022 | |
ERJ advances: state of the art in definitions and diagnosis of COPD Sachin Ananth, John R. Hurst Eur Respir J, 61 (4) 2202318; 10.1183/13993003.02318-2022 | |
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Alvar Agustí, Bartolome R. Celli, Gerard J. Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K. Han, Fernando J. Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Pavord, Nicolas Roche, Sundeep Salvi, Don D. Sin, Dave Singh, Robert Stockley, M. Victorina López Varela, Jadwiga A. Wedzicha, Claus F. Vogelmeier Eur Respir J, 61 (4) 2300239; 10.1183/13993003.00239-2023 | |
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia Ignacio Martin-Loeches, Antoni Torres, Blin Nagavci, Stefano Aliberti, Massimo Antonelli, Matteo Bassetti, Lieuwe Bos, James Chalmers, Lennie Derde, Jan de Waele, Jose Garnacho-Montero, Marin Kollef, Carlos Luna, Rosario Menendez, Michael Niederman, Dimitry Ponomarev, Marcos Restrepo, David Rigau, Marcus Schultz, Emmanuele Weiss, Tobias Welte, Richard Wunderink Eur Respir J, 61 (4) 2200735; 10.1183/13993003.00735-2022 | |
Nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesia: European Respiratory Society technical standard Nicole Beydon, Panayiotis Kouis, June K. Marthin, Philipp Latzin, Murielle Colas, Stephanie D. Davis, Eric Haarman, Amanda Lea Harris, Claire Hogg, Emma Kilbride, Claudia E. Kuehni, Diana Marangu, Kim G. Nielsen, Catherine Pendergrast, Phil Robinson, Nisreen Rumman, Matthew Rutter, Woolf T. Walker, Thomas Ferkol, Jane S. Lucas Eur Respir J, 61 (4) 2202031; 10.1183/13993003.02031-2022 | |
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) Francesco Salton, Paola Confalonieri, Stefano Centanni, Michele Mondoni, Nicola Petrosillo, Paolo Bonfanti, Giuseppe Lapadula, Donato Lacedonia, Antonio Voza, Nicoletta Carpenè, Marcella Montico, Nicolò Reccardini, Gianfranco Umberto Meduri, Barbara Ruaro, Marco Confalonieri Eur Respir J, 61 (4) 2201514; 10.1183/13993003.01514-2022 | |
Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study Frédéric Schlemmer, Simon Valentin, Laurent Boyer, Anne Guillaumot, François Chabot, Clairelyne Dupin, Pierre Le Guen, Gwenael Lorillon, Anne Bergeron, Damien Basille, Julia Delomez, Claire Andrejak, Valentine Bonnefoy, Hélène Goussault, Jean-Baptiste Assié, Pascaline Choinier, Anne-Marie Ruppert, Jacques Cadranel, Maria Chiara Mennitti, Mehdi Roumila, Charlotte Colin, Sven Günther, Olivier Sanchez, Thomas Gille, Lucile Sésé, Yurdagul Uzunhan, Morgane Faure, Maxime Patout, Capucine Morelot-Panzini, Pierantonio Laveneziana, Maeva Zysman, Elodie Blanchard, Chantal Raherison-Semjen, Violaine Giraud, Etienne Giroux-Leprieur, Stéfanie Habib, Nicolas Roche, Anh Tuan Dinh-Xuan, Islem Sifaoui, Pierre-Yves Brillet, Camille Jung, Emmanuelle Boutin, Richard Layese, Florence Canoui-Poitrine, Bernard Maitre Eur Respir J, 61 (4) 2201532; 10.1183/13993003.01532-2022 | |
Mycobacterium avium complex genomics and transmission in a London hospital Andries J. van Tonder, Huw C. Ellis, Colin P. Churchward, Kartik Kumar, Newara Ramadan, Susan Benson, Julian Parkhill, Miriam F. Moffatt, Michael R. Loebinger, William O.C. Cookson Eur Respir J, 61 (4) 2201237; 10.1183/13993003.01237-2022 | |
Obstructive sleep apnoea and 5-year cognitive decline in the elderly Nicola Andrea Marchi, Geoffroy Solelhac, Mathieu Berger, José Haba-Rubio, Nadia Gosselin, Peter Vollenweider, Pedro Marques-Vidal, Julius Popp, Armin von Gunten, Martin Preisig, Bogdan Draganski, Raphael Heinzer Eur Respir J, 61 (4) 2201621; 10.1183/13993003.01621-2022 | |
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone Hsiao-Yen Ma, Jason A. Vander Heiden, Salil Uttarwar, Ying Xi, Elsa-Noah N'Diaye, Ryan LaCanna, Patrick Caplazi, Sarah Gierke, John Moffat, Paul J. Wolters, Ning Ding Eur Respir J, 61 (4) 2200604; 10.1183/13993003.00604-2022 | |
Interstitial lung disease progression after genomic usual interstitial pneumonia testing Sachin Chaudhary, S. Sam Weigt, Manuel L. Ribeiro Neto, Bryan S. Benn, Janelle Vu Pugashetti, Rebecca Keith, Arista Chand, Scott Oh, Fayez Kheir, Vijaya Ramalingam, Joshua J. Solomon, Richart Harper, Joseph A. Lasky, Justin M. Oldham Eur Respir J, 61 (4) 2201245; 10.1183/13993003.01245-2022 | |
Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor Shuzhong Zhang, Chandra L. Shrestha, Frank Robledo-Avila, Devi Jaganathan, Benjamin L. Wisniewski, Nevian Brown, Hanh Pham, Katherine Carey, Amal O. Amer, Luanne Hall-Stoodley, Karen S. McCoy, Shasha Bai, Santiago Partida-Sanchez, Benjamin T. Kopp Eur Respir J, 61 (4) 2102861; 10.1183/13993003.02861-2021 | |
Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis Luca Cavinato, Francesco R. Luly, Valentina Pastore, Daniele Chiappetta, Gloria Sangiorgi, Eva Ferrara, Pia Baiocchi, Giuseppe Mandarello, Giuseppe Cimino, Paola Del Porto, Fiorentina Ascenzioni Eur Respir J, 61 (4) 2200725; 10.1183/13993003.00725-2022 | |
Lung volume reduction surgery versus endobronchial valves: a randomised controlled trial Sara C. Buttery, Winston Banya, Rocco Bilancia, Elizabeth Boyd, Julie Buckley, Neil J. Greening, Kay Housley, Simon Jordan, Samuel V. Kemp, Alan J.B. Kirk, Lorna Latimer, Kelvin Lau, Rod Lawson, Adam Lewis, John Moxham, Sridhar Rathinam, Michael C. Steiner, Sara Tenconi, David Waller, Pallav L. Shah, Nicholas S. Hopkinson Eur Respir J, 61 (4) 2202063; 10.1183/13993003.02063-2022 | |
RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD Hannelore P. Van Eeckhoutte, Chantal Donovan, Richard Y. Kim, Thomas M. Conlon, Meshal Ansari, Haroon Khan, Ranjith Jayaraman, Nicole G. Hansbro, Yves Dondelinger, Tom Delanghe, Allison M. Beal, Brad Geddes, John Bertin, Tom Vanden Berghe, Joyceline De Volder, Tania Maes, Peter Vandenabeele, Bart M. Vanaudenaerde, Dieter Deforce, Sonja Škevin, Filip Van Nieuwerburgh, Fien M. Verhamme, Guy F. Joos, Sobia Idrees, Herbert B. Schiller, Ali Önder Yildirim, Alen Faiz, Mathieu J.M. Bertrand, Guy G. Brusselle, Philip M. Hansbro, Ken R. Bracke Eur Respir J, 61 (4) 2201506; 10.1183/13993003.01506-2022 | |
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA) Ekaterina Khaleva, Anna Rattu, Chris Brightling, Andrew Bush, Apostolos Bossios, Arnaud Bourdin, Kian Fan Chung, Rekha Chaudhuri, Courtney Coleman, Sven-Erik Dahlén, Ratko Djukanovic, Antoine Deschildre, Louise Fleming, Stephen J. Fowler, Atul Gupta, Eckard Hamelmann, Simone Hashimoto, Gunilla Hedlin, Gerard H. Koppelman, Erik Melén, Clare S. Murray, Charles Pilette, Celeste Porsbjerg, Katharine C. Pike, Franca Rusconi, Clare Williams, Birgit Ahrens, Peter Alter, Freja Anckers, Maarten van den Berge, Katharina Blumchen, Guy Brusselle, Graham W. Clarke, Danen Cunoosamy, Barbro Dahlén, Piers Dixey, Andrew Exley, Urs Frey, Erol A. Gaillard, Lisa Giovannini-Chami, Jonathan Grigg, Diana Hartenstein, Liam G. Heaney, Bülent Karadag, Susanne Kaul, Inger Kull, Amelia Licari, Anke H. Maitland-van der Zee, Vera Mahler, Ann-Marie M. Schoos, Prasad Nagakumar, Jenny Negus, Hanna Nielsen, James Paton, Mariëlle Pijnenburg, Valeria Ramiconi, Sofia Romagosa Vilarnau, Stefania Principe, Niels Rutjes, Sejal Saglani, Paul Seddon, Florian Singer, Heribert Staudinger, Steve Turner, Susanne Vijverberg, Tonya Winders, Valentyna Yasinska, Graham Roberts Eur Respir J, 61 (4) 2200606; 10.1183/13993003.00606-2022 | |
Identifying and appraising outcome measures for severe asthma: a systematic review Anna Rattu, Ekaterina Khaleva, Chris Brightling, Sven-Erik Dahlén, Apostolos Bossios, Louise Fleming, Kian Fan Chung, Erik Melén, Ratko Djukanovic, Rekha Chaudhuri, Andrew Exley, Gerard H. Koppelman, Arnaud Bourdin, Franca Rusconi, Celeste Porsbjerg, Courtney Coleman, Clare Williams, Hanna Nielsen, Elizabeth Davin, Phil Taverner, Sofia Romagosa Vilarnau, Graham Roberts Eur Respir J, 61 (4) 2201231; 10.1183/13993003.01231-2022 | |
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond Marcus A. Mall, Gerard J. Criner, Marc Miravitlles, Steven M. Rowe, Claus F. Vogelmeier, David J. Rowlands, Matthias Schoenberger, Pablo Altman Eur Respir J, 61 (4) 2201307; 10.1183/13993003.01307-2022 | |
Idiopathic pulmonary fibrosis: state of the art for 2023 Anna J. Podolanczuk, Carey C. Thomson, Martine Remy-Jardin, Luca Richeldi, Fernando J. Martinez, Martin Kolb, Ganesh Raghu Eur Respir J, 61 (4) 2200957; 10.1183/13993003.00957-2022 | |
Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis Kai-Helge Schmidt, Katrin Milger, Christine Pausch, Doerte Huscher, David Pittrow, Ekkehard Grünig, Gerd Staehler, Henning Gall, Oliver Distler, Dirk Skowasch, Michael Halank, Heinrike Wilkens, Matthias Held, Hans Klose, Marius M. Hoeper Eur Respir J, 61 (4) 2202440; 10.1183/13993003.02440-2022 | |
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism Cindy M.M. de Jong, Chantal Visser, Remy H.H. Bemelmans, Wim G. Boersma, Bram van den Borst, J. Louise I. Burggraaf, Suzanne C. Cannegieter, Arina J. ten Cate-Hoek, F. Nanne Croles, Harald J. Faber, Laura M. Faber, Merel E. Hellemons, Lisa M. Hessels, Menno V. Huisman, Pieter W. Kamphuisen, Stephanie C.E. Koster, Lucia J.M. Kroft, Ivo van der Lee, Jenneke Leentjens, Karina Meijer, Maarten K. Ninaber, Brigitte M. Sondermeijer, Susanne Stads, Anton Vonk Noordegraaf, Kristien Winckers, Marieke J.H.A. Kruip, Frederikus A. Klok Eur Respir J, 61 (4) 2300171; 10.1183/13993003.00171-2023 | |
Muscle sympathetic nerve activity and adaptive servo-ventilation: questions remain Dany Jaffuel, Jean Pierre Mallet, François Roubille, Arnaud Bourdin Eur Respir J, 61 (4) 2300002; 10.1183/13993003.00002-2023 | |
Reply to: Muscle sympathetic nerve activity and adaptive servo-ventilation: questions remain Renaud Tamisier, Jean-Louis Pépin, Patrick Lévy Eur Respir J, 61 (4) 2300247; 10.1183/13993003.00247-2023 | |
What could explain the high prevalence of progressive fibrosing interstitial lung disease in a patient registry? Onofre Moran-Mendoza, Ahmad Al-Jarallah, Salem Alqahtani, Carla Paredes Eur Respir J, 61 (4) 2300019; 10.1183/13993003.00019-2023 | |
Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary Fibrosis Christopher J. Ryerson, Nathan Hambly, Martin Kolb Eur Respir J, 61 (4) 2300208; 10.1183/13993003.00208-2023 | |
“Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics.” M. Badran, A. Khalyfa, A.C. Ericsson, C. Puech, Z. McAdams, S.B. Bender and D. Gozal. Eur Respir J 2023; 61: 2200002.
Eur Respir J, 61 (4) 2250002; 10.1183/13993003.50002-2022 | |